Published in Am J Hum Genet on November 01, 1996
Localization of type 1 diabetes susceptibility to the MHC class I genes HLA-B and HLA-A. Nature (2007) 6.67
HLA DR-DQ haplotypes and genotypes and type 1 diabetes risk: analysis of the type 1 diabetes genetics consortium families. Diabetes (2008) 4.94
Human leukocyte antigen class I B and C loci contribute to Type 1 Diabetes (T1D) susceptibility and age at T1D onset. Hum Immunol (2005) 2.14
The HLA class I A locus affects susceptibility to type 1 diabetes. Hum Immunol (2002) 1.98
Extreme genetic risk for type 1A diabetes. Proc Natl Acad Sci U S A (2006) 1.90
Network for Pancreatic Organ Donors with Diabetes (nPOD): developing a tissue biobank for type 1 diabetes. Diabetes Metab Res Rev (2012) 1.68
HLA genotyping in the international Type 1 Diabetes Genetics Consortium. Clin Trials (2010) 1.61
The insulin A-chain epitope recognized by human T cells is posttranslationally modified. J Exp Med (2005) 1.55
Seven regions of the genome show evidence of linkage to type 1 diabetes in a consensus analysis of 767 multiplex families. Am J Hum Genet (2001) 1.49
Genetics of type 1 diabetes. Clin Chem (2011) 1.37
Staging presymptomatic type 1 diabetes: a scientific statement of JDRF, the Endocrine Society, and the American Diabetes Association. Diabetes Care (2015) 1.36
Genetics of the HLA region in the prediction of type 1 diabetes. Curr Diab Rep (2011) 1.30
Association and interaction of the IL4R, IL4, and IL13 loci with type 1 diabetes among Filipinos. Am J Hum Genet (2003) 1.27
Genetics of type 1 diabetes. Cold Spring Harb Perspect Med (2012) 1.25
HLA class II DR-DQ amino acids and insulin-dependent diabetes mellitus: application of the haplotype method. Am J Hum Genet (1997) 1.19
Genetic linkage of IgA deficiency to the major histocompatibility complex: evidence for allele segregation distortion, parent-of-origin penetrance differences, and the role of anti-IgA antibodies in disease predisposition. Am J Hum Genet (1999) 1.15
Stepwise or linear decrease in penetrance of type 1 diabetes with lower-risk HLA genotypes over the past 40 years. Diabetes (2011) 1.13
A real-time PCR approach for rapid high resolution subtyping of HLA-DRB1*04. J Immunol Methods (2006) 1.04
Genetics of gestational diabetes mellitus and type 2 diabetes. Diabetes Care (2007) 1.03
Pathogenesis of type 1 diabetes: lessons from natural history studies of high-risk individuals. Ann N Y Acad Sci (2013) 1.02
Effects of non-HLA gene polymorphisms on development of islet autoimmunity and type 1 diabetes in a population with high-risk HLA-DR,DQ genotypes. Diabetes (2012) 1.01
Extreme genetic risk for type 1A diabetes in the post-genome era. J Autoimmun (2008) 1.00
Additive and interaction effects at three amino acid positions in HLA-DQ and HLA-DR molecules drive type 1 diabetes risk. Nat Genet (2015) 1.00
Biomarkers for type 1 diabetes. Int J Clin Exp Med (2008) 0.98
Implementation and utilization of genetic testing in personalized medicine. Pharmgenomics Pers Med (2014) 0.97
HLA class II haplotype associations with inflammatory bowel disease in Jewish (Ashkenazi) and non-Jewish caucasian populations. Hum Immunol (2000) 0.96
Association between LTA, TNF and AGER polymorphisms and late diabetic complications. PLoS One (2008) 0.95
HLA class II genotyping of African American type 1 diabetic patients reveals associations unique to African haplotypes. Diabetes (2013) 0.95
Type 1 diabetes risk for human leukocyte antigen (HLA)-DR3 haplotypes depends on genotypic context: association of DPB1 and HLA class I loci among DR3- and DR4-matched Italian patients and controls. Hum Immunol (2008) 0.94
Race-specific type 1 diabetes risk of HLA-DR7 haplotypes. Tissue Antigens (2011) 0.94
Vaccine against autoimmune disease: antigen-specific immunotherapy. Curr Opin Immunol (2013) 0.94
Current approaches to measuring human islet-antigen specific T cell function in type 1 diabetes. Clin Exp Immunol (2010) 0.92
Two genetic loci regulate T cell-dependent islet inflammation and drive autoimmune diabetes pathogenesis. Am J Hum Genet (2000) 0.91
Genetic analysis of the LEW.1AR1-iddm rat: an animal model for spontaneous diabetes mellitus. Mamm Genome (2005) 0.91
Nephropathy in type 1 diabetes is diminished in carriers of HLA-DRB1*04: the genetics of kidneys in diabetes (GoKinD) study. Diabetes (2007) 0.90
A flexible approach for the analysis of rare variants allowing for a mixture of effects on binary or quantitative traits. PLoS Genet (2013) 0.88
Association analysis of SNPs in the IL4R locus with type I diabetes. Genes Immun (2009) 0.87
Analysis of maternal-offspring HLA compatibility, parent-of-origin and non-inherited maternal effects for the classical HLA loci in type 1 diabetes. Diabetes Obes Metab (2009) 0.87
Improving prediction of type 1 diabetes by testing non-HLA genetic variants in addition to HLA markers. Pediatr Diabetes (2013) 0.85
A humanized mouse model of autoimmune insulitis. Diabetes (2014) 0.85
Evidence of stage- and age-related heterogeneity of non-HLA SNPs and risk of islet autoimmunity and type 1 diabetes: the diabetes autoimmunity study in the young. Clin Dev Immunol (2013) 0.84
Type I diabetes mellitus: genetic factors and presumptive enteroviral etiology or protection. J Pathog (2014) 0.82
Evidence for oligogenic inheritance of type 1 diabetes in a large Bedouin Arab family. J Clin Invest (1998) 0.81
Etiopathogenesis of type 1 diabetes mellitus: prognostic factors for the evolution of residual beta cell function. Diabetol Metab Syndr (2009) 0.81
Comparing HLA shared epitopes in French Caucasian patients with scleroderma. PLoS One (2012) 0.81
Type 1 diabetes: primary antigen/peptide/register/trimolecular complex. Immunol Res (2013) 0.81
Type 1 diabetes: A predictable disease. World J Diabetes (2015) 0.80
A new model defines the minimal set of polymorphism in HLA-DQ and -DR that determines susceptibility and resistance to autoimmune diabetes. Biol Direct (2008) 0.80
Association of MHC SNP genotype with susceptibility to type 1 diabetes: a modified survival approach. Diabetes Obes Metab (2009) 0.79
Advances and challenges in biomarker development for type 1 diabetes prediction and prevention using omic technologies. Expert Opin Med Diagn (2010) 0.79
Familial type 1 diabetes mellitus - gender distribution and age at onset of diabetes distinguish between parent-offspring and sib-pair subgroups. Pediatr Diabetes (2009) 0.79
HLA class I and II alleles are associated with microvascular complications of type 1 diabetes. Hum Immunol (2013) 0.79
rs11203203 is associated with type 1 diabetes risk in population pre-screened for high-risk HLA-DR,DQ genotypes. Pediatr Diabetes (2012) 0.78
Multiple HLA epitopes contribute to type 1 diabetes susceptibility. Diabetes (2014) 0.78
Replication and further characterization of a Type 1 diabetes-associated locus at the telomeric end of the major histocompatibility complex. J Diabetes (2011) 0.78
Extensive haplotype diversity in African American mothers and their cord blood units. Tissue Antigens (2012) 0.77
Lessons from type 1 diabetes for understanding natural history and prevention of autoimmune disease. Rheum Dis Clin North Am (2014) 0.77
Disease modifying therapies in type 1 diabetes: Where have we been, and where are we going? Pharmacol Res (2015) 0.76
Interaction between Treg apoptosis pathways, Treg function and HLA risk evolves during type 1 diabetes pathogenesis. PLoS One (2012) 0.76
Three microsatellites from the T1DGC MHC data set show highly significant association with type 1 diabetes, independent of the HLA-DRB1, -DQA1 and -DQB1 genes. Diabetes Obes Metab (2009) 0.76
KIR haplotypes are associated with late-onset type 1 diabetes in European-American families. Genes Immun (2015) 0.76
Targeted Deep Sequencing in Multiple-Affected Sibships of European Ancestry Identifies Rare Deleterious Variants in PTPN22 That Confer Risk for Type 1 Diabetes. Diabetes (2015) 0.75
Temporal trends of HLA, CTLA-4 and PTPN22 genotype frequencies among type 1 diabetes in Continental Italy. PLoS One (2013) 0.75
Thymic self-antigen expression for the design of a negative/tolerogenic self-vaccine against type 1 diabetes. Clin Dev Immunol (2011) 0.75
From markers to molecular mechanisms: type 1 diabetes in the post-GWAS era. Rev Diabet Stud (2012) 0.75
Genetic Variants of PTPN2 Gene in Chinese Children with Type 1 Diabetes Mellitus. Med Sci Monit (2015) 0.75
Growth and Risk for Islet Autoimmunity and Progression to Type 1 Diabetes in Early Childhood: The Environmental Determinants of Diabetes in the Young Study. Diabetes (2016) 0.75
HLA-DRB1*03 as a risk factor for microalbuminuria in same duration of type 1 diabetes: a case control study. BMC Nephrol (2016) 0.75
The relationships between HLA class II alleles and antigens with gestational diabetes mellitus: A meta-analysis. Sci Rep (2016) 0.75
Cytotoxic T-lymphocyte-associated protein 4 +49A/G polymorphisms contribute to the risk of type 1 diabetes in children: An updated systematic review and meta-analysis with trial sequential analysis. Oncotarget (2017) 0.75
Assessment of type 1 diabetes risk conferred by HLA-DRB1, INS-VNTR and PTPN22 genes using the Bayesian network approach. PLoS One (2013) 0.75
Endoplasmic reticulum stress in beta cells and autoimmune diabetes. Curr Opin Immunol (2016) 0.75
Genetics: new HLA variants could predict T1DM risk in African Americans. Nat Rev Endocrinol (2013) 0.75
Early prediction of autoimmune (type 1) diabetes. Diabetologia (2017) 0.75
Can non-HLA Single Nucleotide Polymorphisms Help Stratify Risk in TrialNet Relatives at Risk for Type 1 Diabetes? J Clin Endocrinol Metab (2017) 0.75
The Clinical Course of Patients with Preschool Manifestation of Type 1 Diabetes Is Independent of the HLA DR-DQ Genotype. Genes (Basel) (2017) 0.75
Emerging Concepts on Disease-Modifying Therapies in Type 1 Diabetes. Curr Diab Rep (2017) 0.75
On estimating the relation between blood group and disease. Ann Hum Genet (1955) 26.39
HLA-DQ beta gene contributes to susceptibility and resistance to insulin-dependent diabetes mellitus. Nature (1987) 10.70
A polymorphic locus near the human insulin gene is associated with insulin-dependent diabetes mellitus. Diabetes (1984) 10.09
A comparison of sib-pair linkage tests for disease susceptibility loci. Genet Epidemiol (1985) 9.70
Genetic analysis of amplified DNA with immobilized sequence-specific oligonucleotide probes. Proc Natl Acad Sci U S A (1989) 7.79
A genome-wide search for human type 1 diabetes susceptibility genes. Nature (1994) 7.13
HLA and insulin gene associations with IDDM. Genet Epidemiol (1989) 6.53
Assessing the role of HLA-linked and unlinked determinants of disease. Am J Hum Genet (1987) 5.47
Genetic analysis of IDDM: summary of GAW5 IDDM results. Genet Epidemiol (1989) 5.06
HL-A antigens and diabetes mellitus. Lancet (1974) 4.42
Allelic sequence variation of the HLA-DQ loci: relationship to serology and to insulin-dependent diabetes susceptibility. Proc Natl Acad Sci U S A (1988) 4.19
MHC class-II molecules and autoimmunity. Annu Rev Immunol (1991) 3.41
A locus on chromosome 15q26 (IDDM3) produces susceptibility to insulin-dependent diabetes mellitus. Nat Genet (1994) 3.03
Linkage disequilibrium mapping of a type 1 diabetes susceptibility gene (IDDM7) to chromosome 2q31-q33. Nat Genet (1995) 2.93
Genetic heterogeneity, modes of inheritance, and risk estimates for a joint study of Caucasians with insulin-dependent diabetes mellitus. Am J Hum Genet (1988) 2.88
Genetic mapping of a susceptibility locus for insulin-dependent diabetes mellitus on chromosome 11q. Nature (1994) 2.82
Letter: HL-A antigens and diabetes mellitus. Lancet (1974) 2.42
Polymorphism, recombination, and linkage disequilibrium within the HLA class II region. J Immunol (1992) 2.39
Histocompatibility (HL-A) antigens, lymphocytotoxic antibodies and tissue antibodies in patients with diabetes mellitus. Diabetes (1973) 2.21
Relative predispositional effects (RPEs) of marker alleles with disease: HLA-DR alleles and Graves disease. Am J Hum Genet (1989) 2.03
Investigation of the mode of inheritance of the HLA associated diseases by the method of antigen genotype frequencies among diseased individuals. Tissue Antigens (1983) 1.97
A diabetes-susceptible HLA haplotype is best defined by a combination of HLA-DR and -DQ alleles. J Clin Invest (1989) 1.72
Identification of susceptibility loci for insulin-dependent diabetes mellitus by trans-racial gene mapping. Nature (1989) 1.64
Age-dependent HLA genetic heterogeneity of type 1 insulin-dependent diabetes mellitus. J Clin Invest (1992) 1.63
Combinations of specific DRB1, DQA1, DQB1 haplotypes are associated with insulin-dependent diabetes mellitus in Sardinia. Hum Immunol (1993) 1.52
HLA-DR, DQ and DP typing using PCR amplification and immobilized probes. Eur J Immunogenet (1991) 1.50
HLA class II alleles and susceptibility and resistance to insulin dependent diabetes mellitus in Mexican-American families. Nat Genet (1993) 1.50
HLA genotypic study of insulin-dependent diabetes the excess of DR3/DR4 heterozygotes allows rejection of the recessive hypothesis. Diabetes (1983) 1.45
Rapid typing of HLA-DQB1 DNA polymorphism using nonradioactive oligonucleotide probes and amplified DNA. Immunogenetics (1991) 1.45
Affected-sib-pair mapping of a novel susceptibility gene to insulin-dependent diabetes mellitus (IDDM8) on chromosome 6q25-q27. Am J Hum Genet (1995) 1.42
Nomenclature for factors of the HLA system, 1995. Tissue Antigens (1995) 1.34
Association of HLA-DPB1*0301 with IDDM in Mexican-Americans. Diabetes (1996) 1.32
Analysis of HLA-DP allelic sequence polymorphism using the in vitro enzymatic DNA amplification of DP-alpha and DP-beta loci. J Immunol (1988) 1.26
Rapid HLA-DPB typing using enzymatically amplified DNA and nonradioactive sequence-specific oligonucleotide probes. Immunogenetics (1990) 1.25
Transcomplementation of HLA genes in IDDM. HLA-DQ alpha- and beta-chains produce hybrid molecules in DR3/4 heterozygotes. Diabetes (1987) 1.25
Three-allele synergistic mixed model for insulin-dependent diabetes mellitus. Diabetes (1986) 1.24
Localization of predisposition to Hodgkin disease in the HLA class II region. Am J Hum Genet (1994) 1.23
The distribution of DR4 haplotypes in Sardinia suggests a primary association of type I diabetes with DRB1 and DQB1 loci. Hum Immunol (1995) 1.18
Complementation and maternal effect in insulin-dependent diabetes. Am J Hum Genet (1991) 1.12
Genetic analysis of HLA class II alleles and susceptibility to type 1 (insulin-dependent) diabetes mellitus in Japanese subjects. Diabetologia (1992) 1.12
Overview: the major histocompatibility complex and insulin dependent diabetes mellitus. Baillieres Clin Endocrinol Metab (1991) 1.11
Preferential transmission of diabetic alleles within the HLA gene complex. N Engl J Med (1986) 1.11
Rapid typing of DNA sequence polymorphism at the HLA-DRB1 locus using the polymerase chain reaction and nonradioactive oligonucleotide probes. Hum Immunol (1991) 1.09
Is juvenile diabetes a viral disease? Ann Med (1993) 1.05
Excess of maternal HLA-DR3 antigens in HLA DR3,4 positive type 1 (insulin-dependent) diabetic patients. Diabetologia (1990) 1.00
HLA-DQ beta sequence polymorphism and genetic susceptibility to IDDM. Diabetes (1990) 0.97
Implication of specific DQB1 alleles in genetic susceptibility and resistance by identification of IDDM siblings with novel HLA-DQB1 allele and unusual DR2 and DR1 haplotypes. Diabetes (1991) 0.97
The HOXD8 locus (2q31) is linked to type I diabetes. Interaction with chromosome 6 and 11 disease susceptibility genes. Diabetes (1995) 0.96
Association of insulin-dependent diabetes mellitus in Taiwan with HLA class II DQB1 and DRB1 alleles. Hum Immunol (1993) 0.95
No difference in the parental origin of susceptibility HLA class II haplotypes among Norwegian patients with insulin-dependent diabetes mellitus. Am J Hum Genet (1995) 0.94
Non-HLA region genes in insulin dependent diabetes mellitus. Baillieres Clin Endocrinol Metab (1991) 0.94
Parental origin of diabetes-associated HLA types in sibling pairs with type I diabetes. Diabetes (1994) 0.92
Testing parental imprinting in insulin-dependent diabetes mellitus by the marker-association-segregation-chi 2 method. Am J Hum Genet (1995) 0.91
Primary association of HLA-DQw8 with type I diabetes in DR4 patients. Diabetes (1989) 0.91
Sequence analysis of HLA class II genes from insulin-dependent diabetic individuals. Hum Immunol (1988) 0.89
Particular HLA-DQ alpha beta heterodimer associated with IDDM susceptibility in both DR4-DQw4 Japanese and DR4-DQw8/DRw8-DQw4 whites. Diabetes (1991) 0.89
Association of HLA-DQw3 (TA10-) with type I diabetes occurs with DR3/4 but not DR1/4 patients. Diabetes (1988) 0.89
HLA-DP variation as additional risk factor in IDDM. Diabetes (1990) 0.88
HLA class II sequences and genetic susceptibility to insulin dependent diabetes mellitus. Baillieres Clin Endocrinol Metab (1991) 0.85
HLA-encoded susceptibility to insulin-dependent diabetes mellitus is determined by DR and DQ genes as well as their linkage disequilibria in a Chinese population. Hum Immunol (1995) 0.82
Analysis of HLA class II polymorphism using polymerase chain reaction. Arch Pathol Lab Med (1993) 0.81
Exposure to superantigens as an immunogenetic explanation of type I diabetes mini-epidemics. J Pediatr Endocrinol Metab (1995) 0.80
T-cell recognition of class II products that result from the combined presence of two different HLA haplotypes. Hum Immunol (1992) 0.79
A novel HLA-DRB1-DR2 allele associated with HLA mistyping. Immunogenetics (1993) 0.79
HLA-DR peptide-induced alloreactive T cell lines reveal an HLA-DR sequence that can be both "dominant" and "cryptic": evidence for allele-specific processing. Eur J Immunol (1992) 0.79
Primer-directed enzymatic amplification of DNA with a thermostable DNA polymerase. Science (1988) 220.77
Enzymatic amplification of beta-globin genomic sequences and restriction site analysis for diagnosis of sickle cell anemia. Science (1985) 95.08
Direct cloning and sequence analysis of enzymatically amplified genomic sequences. Science (1986) 19.54
Generation of single-stranded DNA by the polymerase chain reaction and its application to direct sequencing of the HLA-DQA locus. Proc Natl Acad Sci U S A (1988) 18.72
Analysis of enzymatically amplified beta-globin and HLA-DQ alpha DNA with allele-specific oligonucleotide probes. Nature (1986) 17.77
Mutational processes of simple-sequence repeat loci in human populations. Proc Natl Acad Sci U S A (1994) 11.84
Amplification and analysis of DNA sequences in single human sperm and diploid cells. Nature (1988) 10.84
Length mutations in human mitochondrial DNA: direct sequencing of enzymatically amplified DNA. Nucleic Acids Res (1987) 10.38
DNA typing from single hairs. Nature (1988) 9.32
Phenotypic expression in E. coli of a DNA sequence coding for mouse dihydrofolate reductase. Nature (1978) 8.76
Characterization of beta-thalassaemia mutations using direct genomic sequencing of amplified single copy DNA. Nature (1987) 8.58
Genetic analysis of amplified DNA with immobilized sequence-specific oligonucleotide probes. Proc Natl Acad Sci U S A (1989) 7.79
Bone mineral density, osteoporosis, and osteoporotic fractures: a genome-wide association study. Lancet (2008) 7.05
The effects of social status on biological aging as measured by white-blood-cell telomere length. Aging Cell (2006) 6.80
HLA and insulin gene associations with IDDM. Genet Epidemiol (1989) 6.53
The effect of a selected locus on linked neutral loci. Genetics (1977) 4.53
Allelic sequence variation of the HLA-DQ loci: relationship to serology and to insulin-dependent diabetes susceptibility. Proc Natl Acad Sci U S A (1988) 4.19
Analysis of DNA extracted from formalin-fixed, paraffin-embedded tissues by enzymatic amplification and hybridization with sequence-specific oligonucleotides. Biochem Biophys Res Commun (1987) 4.05
The polymerase chain reaction. Trends Genet (1989) 3.95
Nomenclature for the major histocompatibility complexes of different species: a proposal. Immunogenetics (1990) 3.53
Western Blot analysis of the antigens of Toxoplasma gondii recognized by human IgM and IgG antibodies. J Immunol (1983) 3.53
Lack of association between early exposure to cow's milk protein and beta-cell autoimmunity. Diabetes Autoimmunity Study in the Young (DAISY) JAMA (1996) 3.52
Determining the mode of inheritance of RFLP-associated diseases using the affected sib-pair method. Am J Hum Genet (1986) 3.49
Rapid prenatal diagnosis of sickle cell anemia by a new method of DNA analysis. N Engl J Med (1987) 3.44
A sensitive radioimmunoassay for detecting products translated from cloned DNA fragments. Cell (1978) 3.30
Limited heterogeneity of rearranged T-cell receptor V alpha transcripts in brains of multiple sclerosis patients. Nature (1990) 3.30
Newborn screening for HLA markers associated with IDDM: diabetes autoimmunity study in the young (DAISY). Diabetologia (1996) 3.23
Nomenclature for factors of the HLA system, 2010. Tissue Antigens (2010) 3.22
Influence of blood lead on the ability and attainment of children in Edinburgh. Lancet (1987) 3.08
Analysis of RAS gene mutations in acute myeloid leukemia by polymerase chain reaction and oligonucleotide probes. Proc Natl Acad Sci U S A (1988) 2.99
Ancestral Asian source(s) of new world Y-chromosome founder haplotypes. Am J Hum Genet (1999) 2.89
HLA class II allelic variation and susceptibility to pemphigus vulgaris. Proc Natl Acad Sci U S A (1988) 2.72
High-resolution, high-throughput HLA genotyping by next-generation sequencing. Tissue Antigens (2009) 2.64
Diagnosis of sickle cell anemia and beta-thalassemia with enzymatically amplified DNA and nonradioactive allele-specific oligonucleotide probes. N Engl J Med (1988) 2.64
Properties of equilibria in multi-locus genetic systems. Genetics (1977) 2.63
A two locus model for juvenile diabetes. Ann Hum Genet (1980) 2.63
Measuring the strength of associations between HLA antigens and diseases. Tissue Antigens (1981) 2.63
Population variation of human mtDNA control region sequences detected by enzymatic amplification and sequence-specific oligonucleotide probes. Am J Hum Genet (1991) 2.56
Distinct roles for lymphotoxin-alpha and tumor necrosis factor in organogenesis and spatial organization of lymphoid tissue. Eur J Immunol (1997) 2.53
Preferential PCR amplification of alleles: mechanisms and solutions. PCR Methods Appl (1992) 2.47
Polymorphism, recombination, and linkage disequilibrium within the HLA class II region. J Immunol (1992) 2.39
Recommendations for standardization and phenotype definitions in genetic studies of osteoarthritis: the TREAT-OA consortium. Osteoarthritis Cartilage (2010) 2.39
Evidence for balancing selection at HLA. Genetics (1983) 2.35
After the smoke has cleared: evaluation of the impact of a new national smoke-free law in New Zealand. Tob Control (2008) 2.35
A two-locus neutrality test: applications to humans, E. coli and lodgepole pine. Genetics (1986) 2.34
Detecting disease-predisposing variants: the haplotype method. Am J Hum Genet (1997) 2.33
Segmental expression of Hox-2 homoeobox-containing genes in the developing mouse hindbrain. Nature (1989) 2.23
The affected sib method. IV. Sib trios. Ann Hum Genet (1985) 2.22
Revised U.K. guidelines for the management of cutaneous melanoma 2010. Br J Dermatol (2010) 2.22
Multiple spatially specific enhancers are required to reconstruct the pattern of Hox-2.6 gene expression. Genes Dev (1991) 2.20
High blood pressure treatment facilities. Survey in greater New York area. N Y State J Med (1979) 2.18
Efficacy of dexmedetomidine compared with midazolam for sedation in adult intensive care patients: a systematic review. Br J Anaesth (2013) 2.17
Structure, sequence and polymorphism in the HLA-D region. Immunol Rev (1985) 2.16
HLA-Bw60 increases susceptibility to ankylosing spondylitis in HLA-B27+ patients. Arthritis Rheum (1989) 2.14
Hippocampal volume in first-episode psychoses and chronic schizophrenia: a high-resolution magnetic resonance imaging study. Arch Gen Psychiatry (1999) 2.14
A multilocus genotyping assay for candidate markers of cardiovascular disease risk. Genome Res (1999) 2.13
Association mapping of disease loci, by use of a pooled DNA genomic screen. Am J Hum Genet (1997) 2.07
A review of theoretical aspects of HLA and disease associations. Theor Popul Biol (1981) 2.06
Relative predispositional effects (RPEs) of marker alleles with disease: HLA-DR alleles and Graves disease. Am J Hum Genet (1989) 2.03
Selection for T-cell receptor V beta-D beta-J beta gene rearrangements with specificity for a myelin basic protein peptide in brain lesions of multiple sclerosis. Nature (1993) 2.01
Nomenclature for factors of the HLA system, 1990. Tissue Antigens (1991) 1.98
Investigation of the mode of inheritance of the HLA associated diseases by the method of antigen genotype frequencies among diseased individuals. Tissue Antigens (1983) 1.97
Disequilibrium pattern analysis. I. Theory. Genetics (1987) 1.92
Homozygous parent affected sib pair method for detecting disease predisposing variants: application to insulin dependent diabetes mellitus. Genet Epidemiol (1993) 1.91
Nomenclature for factors of the HLA system, 2002. Tissue Antigens (2002) 1.89
Recent origin of HLA-DRB1 alleles and implications for human evolution. Nat Genet (1998) 1.89
Differentiation between African populations is evidenced by the diversity of alleles and haplotypes of HLA class I loci. Tissue Antigens (2004) 1.86
Role of genetic variation at the fibrinogen locus in determination of plasma fibrinogen concentrations. Lancet (1987) 1.85
Harvesting the genome's bounty: integrative genomics. Cold Spring Harb Symp Quant Biol (2003) 1.84
Identifying complex disease genes: progress and paradigms. Nat Genet (1994) 1.84
A multi-site study using high-resolution HLA genotyping by next generation sequencing. Tissue Antigens (2011) 1.81
The changing epidemiology of infantile hypertrophic pyloric stenosis in Scotland. Arch Dis Child (2008) 1.79
Relative predispositional effects of HLA class II DRB1-DQB1 haplotypes and genotypes on type 1 diabetes: a meta-analysis. Tissue Antigens (2007) 1.77
How selection shapes variation of the human major histocompatibility complex: a review. Ann Hum Genet (2001) 1.75
HLA-DQ alpha allele and genotype frequencies in various human populations, determined by using enzymatic amplification and oligonucleotide probes. Am J Hum Genet (1990) 1.72
A diabetes-susceptible HLA haplotype is best defined by a combination of HLA-DR and -DQ alleles. J Clin Invest (1989) 1.72
A distinct Hox code for the branchial region of the vertebrate head. Nature (1991) 1.70
Crimean-Congo hemorrhagic fever in Europe: current situation calls for preparedness. Euro Surveill (2010) 1.69
The HLA class II locus DPB1 can influence susceptibility to type 1 diabetes. Diabetes (2000) 1.69
Characterization of recombination in the HLA class II region. Am J Hum Genet (1997) 1.69
Quantitative determination of bone marrow transplant engraftment using fluorescent polymerase chain reaction primers for human identity markers. Blood (1995) 1.68
Effects of anesthesia on functional activation of cerebral blood flow and metabolism. Proc Natl Acad Sci U S A (2001) 1.67
MHC microsatellite diversity and linkage disequilibrium among common HLA-A, HLA-B, DRB1 haplotypes: implications for unrelated donor hematopoietic transplantation and disease association studies. Tissue Antigens (2005) 1.65
Isolation of a cDNA clone for the human HLA-DR antigen alpha chain by using a synthetic oligonucleotide as a hybridization probe. Proc Natl Acad Sci U S A (1982) 1.64
Ontario. Proliferative and necrotizing pneumonia (PNP) of swine: the Ontario situation. Can Vet J (1991) 1.63
Serum adiponectin and bone mineral density in women. J Clin Endocrinol Metab (2007) 1.63
Multi-locus candidate gene polymorphisms and risk of myocardial infarction: a population-based, prospective genetic analysis. J Thromb Haemost (2006) 1.61
PyPop update--a software pipeline for large-scale multilocus population genomics. Tissue Antigens (2007) 1.60
Investigating the HLA component in rheumatoid arthritis: an additive (dominant) mode of inheritance is rejected, a recessive mode is preferred. Genet Epidemiol (1991) 1.60
Lead exposure in a firing range. Am J Public Health (1987) 1.58
Nomenclature for factors of the HLA system, 1991. WHO Nomenclature Committee for factors of the HLA system. Tissue Antigens (1992) 1.58
Nomenclature for factors of the HLA system, 2004. Tissue Antigens (2005) 1.57
Multifactor dimensionality reduction reveals gene-gene interactions associated with multiple sclerosis susceptibility in African Americans. Genes Immun (2006) 1.56